Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -33.86%66.51M | 285.09%53.01M | -37.46%19.47M | -61.80%10.71M | -160.38%-16.68M | 60.35%100.56M | -60.61%13.77M | -49.43%31.13M | 68.43%28.05M | 154.76%27.62M |
Net income from continuing operations | 527.44%27.31M | 3,119.18%7.05M | 23.10%17.59M | 231.86%11.39M | 64.16%-8.72M | -102.18%-6.39M | -99.68%219K | -77.60%14.29M | -97.34%3.43M | -174.05%-24.33M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | 64.30%-1M | --0 | ---- | ---- | ---- |
Depreciation and amortization | 10.67%8.05M | 5.77%2.07M | 9.84%2.05M | 10.37%1.98M | 17.70%1.95M | 9.12%7.28M | 35.13%1.96M | 25.50%1.87M | -10.39%1.79M | -4.22%1.66M |
Other non cash items | 433.04%5.97M | 5.24%-1.07M | 0.47%1.7M | 0.80%-1.12M | 283.16%6.46M | 2.94%1.12M | 0.71%-1.13M | 0.48%1.69M | 0.88%-1.13M | 0.36%1.69M |
Change In working capital | -126.20%-16.04M | 392.27%32.73M | -251.00%-11.54M | -164.77%-11.11M | -187.74%-26.12M | 120.51%61.21M | 111.19%6.65M | 128.24%7.64M | 114.35%17.16M | 132.22%29.76M |
-Change in receivables | -105.48%-2.37M | 1,116.07%28.37M | -735.89%-12.65M | -236.03%-16.48M | -105.34%-1.62M | 375.61%43.27M | 114.23%2.33M | -103.51%-1.51M | 132.47%12.11M | 692.50%30.34M |
-Change in inventory | -609.31%-19.91M | -72.51%-9.53M | -98.05%60K | -114.25%-656K | -657.90%-9.78M | 112.07%3.91M | -123.66%-5.53M | 107.14%3.08M | -8.97%4.61M | 109.90%1.75M |
-Change in prepaid assets | 33.45%-3.11M | 28,039.13%6.43M | -119.62%-3.25M | 20.24%-1.49M | -268.10%-4.8M | -103.16%-4.67M | -100.08%-23K | -101.94%-1.48M | -105.78%-1.87M | -110.78%-1.3M |
-Change in payables and accrued expense | -31.38%14.93M | -18.85%8.94M | -27.07%6.19M | 178.36%8.81M | -895.36%-9.01M | 148.14%21.76M | 305.75%11.02M | 340.85%8.48M | 34.55%3.17M | 97.95%-905K |
-Change in other current assets | -308.77%-1.19M | -95.00%-312K | -2,977.78%-777K | -942.31%-219K | -82.57%118K | 555.17%570K | -715.38%-160K | 3.85%27K | -69.05%26K | 1,481.63%677K |
-Change in other current liabilities | -20.89%-4.39M | -17.40%-1.17M | -16.21%-1.11M | -22.35%-1.08M | -29.26%-1.03M | -16.13%-3.63M | -30.96%-994K | -38.95%-956K | -1.61%-886K | 1.61%-793K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -33.86%66.51M | 285.09%53.01M | -37.46%19.47M | -61.80%10.71M | -160.38%-16.68M | 60.35%100.56M | -60.61%13.77M | -49.43%31.13M | 68.43%28.05M | 154.76%27.62M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 88.28%-18.04M | 215.43%23.37M | 85.42%-15.47M | -216.36%-28.77M | 105.41%2.83M | 51.29%-153.93M | 38.60%-20.24M | 10.90%-106.07M | -52.91%24.72M | 75.83%-52.33M |
Net PPE purchase and sale | -54.78%-6.35M | -101.86%-3.48M | -287.90%-1.35M | -3.73%-779K | 41.62%-749K | 42.51%-4.1M | -8.57%-1.72M | 72.91%-347K | 74.22%-751K | 5.52%-1.28M |
Net intangibles purchase and sale | --0 | --0 | ---- | ---- | ---- | 0.00%1M | --0 | ---- | ---- | ---- |
Net investment purchase and sale | 92.25%-11.68M | 244.95%26.84M | 86.77%-14.12M | -209.87%-27.99M | 107.01%3.58M | 51.32%-150.82M | 40.98%-18.52M | 9.37%-106.73M | -53.19%25.47M | 76.27%-51.05M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 88.28%-18.04M | 215.43%23.37M | 85.42%-15.47M | -216.36%-28.77M | 105.41%2.83M | 51.29%-153.93M | 38.60%-20.24M | 10.90%-106.07M | -52.91%24.72M | 75.83%-52.33M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -7,460.53%-102.02M | -5,667.29%-98.88M | -17.30%2.48M | -381.29%-1.42M | -36.02%-4.2M | -92.90%1.39M | 1,060.78%1.78M | -62.84%2.99M | -128.60%-294K | -130.04%-3.09M |
Net common stock issuance | ---100M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | -7.68%7.29M | -20.63%1.6M | -21.64%2.73M | -69.59%419K | 149.90%2.54M | -59.56%7.9M | 1,220.92%2.02M | -56.81%3.48M | 34.05%1.38M | -90.12%1.02M |
Net other financing activities | -42.97%-9.31M | -95.51%-479K | 48.35%-251K | -9.69%-1.83M | -64.20%-6.74M | ---6.51M | ---245K | ---486K | ---1.67M | ---4.11M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -7,460.53%-102.02M | -5,667.29%-98.88M | -17.30%2.48M | -381.29%-1.42M | -36.02%-4.2M | -92.90%1.39M | 1,060.78%1.78M | -62.84%2.99M | -128.60%-294K | -130.04%-3.09M |
Net cash flow | ||||||||||
Beginning cash position | -25.55%150.56M | -22.72%119.61M | -50.33%112.77M | -24.21%132.3M | -25.55%150.56M | -53.66%202.21M | -22.13%154.78M | -8.93%227.03M | -2.83%174.56M | -53.66%202.21M |
Current changes in cash | -3.00%-53.54M | -378.68%-22.5M | 109.00%6.48M | -137.10%-19.47M | 35.07%-18.05M | 77.76%-51.98M | -320.24%-4.7M | -45.56%-71.95M | -25.23%52.47M | 89.17%-27.8M |
Effect of exchange rate changes | -366.05%-862K | -300.42%-960K | 219.02%363K | -6,300.00%-64K | -233.11%-201K | 173.14%324K | -63.49%479K | 72.22%-305K | 99.81%-1K | 212.69%151K |
End cash Position | -36.13%96.15M | -36.13%96.15M | -22.72%119.61M | -50.33%112.77M | -24.21%132.3M | -25.55%150.56M | -25.55%150.56M | -22.13%154.78M | -8.93%227.03M | -2.83%174.56M |
Free cash flow | -37.63%60.16M | 311.30%49.53M | -41.13%18.12M | -63.61%9.93M | -166.17%-17.43M | 73.56%96.46M | -63.90%12.04M | -48.93%30.78M | 98.68%27.3M | 150.85%26.34M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |